ZHANG Huiyong, LI Lin, CHEN Xiguang. Effect of Yiqi Huoxue Tongmai Decoction in the treatment of elderly patients with cerebral infarction complicated with deep venous thrombosis of lower extremities[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 62-65. DOI: 10.7619/jcmp.202017016
Citation: ZHANG Huiyong, LI Lin, CHEN Xiguang. Effect of Yiqi Huoxue Tongmai Decoction in the treatment of elderly patients with cerebral infarction complicated with deep venous thrombosis of lower extremities[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 62-65. DOI: 10.7619/jcmp.202017016

Effect of Yiqi Huoxue Tongmai Decoction in the treatment of elderly patients with cerebral infarction complicated with deep venous thrombosis of lower extremities

More Information
  • Received Date: June 27, 2020
  • Available Online: September 29, 2020
  • Objective To observe the effect of Yiqi Huoxue Tongmai Decoction in the treatment of elderly patients with cerebral infarction complicated with deep venous thrombosis of lower extremities and its effect on coagulation function. Methods A total of 125 elderly patients with cerebral infarction complicated with deep venous thrombosis of the lower extremities were selected as research objects. They were divided into control group(n=62)and observation group(n=63)by random number method. The control group was given low molecular weight heparin sodium injection and air pressure type blood circulation driven pump, and the observation group was treated with Yiqi Huoxue Tongmai Decoction on the basis of the control group. Two weeks later, the clinical effects, coagulation function, re-canalization rate and occurrence of complications of the two groups were compared. Results After treatment, the clinical efficacy and re-canalization rate of the observation group were better than those of the control group(P<0.05). Partial thromboplastin time(APTT)of the observation group was significantly higher than that of the control group, and the levels of thrombin time(TT), plasma fibrinogen(FIB)and D-dimer(D-D)were significantly lower than those of the control group(P<0.05). The complication rate of the observation group was significantly lower than that of the control group(P<0.05). Conclusion Adjuvant therapy of Yiqi Huoxue Tongmai Decoction for elderly patients with cerebral infarction and DVT can improve the blood coagulation function and promote the re-canalization of blood vessels, improve the therapeutic effect and reduce the incidence of complications.
  • 曹霞. 16例脑梗死合并下肢深静脉血栓的护理体会[J]. 实用临床护理学电子杂志, 2017, 2(19): 67-69.
    陈玉桃, 吕畅, 陈少敏, 等. 多种方法预防ICU长期住院患者下肢深静脉血栓形成的效果评价[J]. 中国全科医学, 2017, 20(3): 318-322.
    雷权. 活血通脉汤联合西药治疗瘀阻脉络型下肢血栓性浅静脉炎疗效观察[J]. 陕西中医, 2017, 38(10): 1443-1444.
    中国中西医结合学会神经科专业委员会. 中国脑梗死中西医结合诊治指南(2017)[J]. 中国中西医结合杂志, 2018, 38(2): 136-144.
    中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第3版)[J]. 中国血管外科杂志: 电子版, 2017, 9(4): 250-257.
    刘炳林. 药物临床试验中疗效评价指标及常见评价方法[J]. 中国新药杂志, 2016, 25(18): 2074-2077.
    欧阳罗丹, 胡小松, 牛明, 等. 基于网络药理学的水蛭活血化瘀的作用机制研究[J]. 中国中药杂志, 2018, 43(9): 1901-1906.
    韩盟帝, 马飞祥, 汪亚楠, 等. 基于网络药理学探讨红花活性成分及药理作用机制[J]. 内蒙古医科大学学报, 2019, 41(2): 126-130.
    袁晓旭, 杨明明, 赵桂琴. 郁金化学成分及药理作用研究进展[J]. 承德医学院学报, 2016, 33(6): 487-489.
    王雅莉, 胡光, 张倩, 等. 活血化瘀中药丹参药对的研究进展[J]. 重庆理工大学学报: 自然科学版, 2020, 34(3): 197-204.
    马秀, 刘少静, 张婉莹, 等. 黄芪多糖的分离纯化及药理作用研究进展[J]. 化学工程师, 2019, 33(8): 50-53.
    许筱凰, 李婷, 王一涛, 等. 桃仁的研究进展[J]. 中草药, 2015, 46(17): 2649-2655.
  • Related Articles

    [1]MENG Lijun, ZHANG Lanfang, QIN Lei, LI Wenjing, SHEN Peijun, CHEN Xu, GUO Xiaohe. Values of serum tumor necrosis factor-α stimulated gene 6 protein and type ⅩⅥ collagen in predicting prognosis of patients with ulcerative colitis[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 87-90, 95. DOI: 10.7619/jcmp.20243615
    [2]ZHANG Xiaohui. Efficacy of mesalazine alone and live bifidobacterium in combination on the treatment of ulcerative colitis and their effects on TNF-α, IL-6 and IL-8 levels[J]. Journal of Clinical Medicine in Practice, 2018, (3): 112-114. DOI: 10.7619/jcmp.201803032
    [3]WEI Xuefei, XU Pei, CHEN Zairong, GUO Wanhua. Expressions and significance of serum IFN-γ,IL-4, IL-6 and IL-10 in treatment of patients with renal cell carcinoma[J]. Journal of Clinical Medicine in Practice, 2015, (7): 68-70. DOI: 10.7619/jcmp.201507019
    [4]ZHANG Hu, LI Zhi. Effect of Astragalus injection on serum tumor necrosis factor-α, interleukin-6 and angiotensin Ⅱ in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2014, (23): 17-19. DOI: 10.7619/jcmp.201423006
    [5]ZHANG Mingsen, WANG Bin, SUN Yang. Effects of different intravascular volume expansion solutions on serum levels of TNF-α and IL-6 in perioperative patients with craniocerebral trauma[J]. Journal of Clinical Medicine in Practice, 2014, (21): 52-54. DOI: 10.7619/jcmp.201421015
    [6]QIU Zhenqin, DU Zhongde, XU Jiagang. Influence of Danhong injection on the level of serum interleukin-6 and Interleukin-10 in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2014, (19): 17-19. DOI: 10.7619/jcmp.201419006
    [7]BAI Yun, QIU Chuxiong, XUE Weixin, LIN Feng, HUANG Shouyuan, NING Liangzhong, ZHANG Chenghao, YAO Yongzhi. Clinical efficacy of Shenkang Injection and its influence on C-reactive protein and interleukin-6 levels in patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2014, (15): 17-19. DOI: 10.7619/jcmp.201415006
    [8]WU Yiping. Clinical significance of serum tumor necrosis factor-α and interleukin-6 in measuring acute intussusception in the infants[J]. Journal of Clinical Medicine in Practice, 2013, (24): 75-77. DOI: 10.7619/jcmp.201324022
    [9]MO Liya, WU Yonghua, WANG Minhong. Association of IL-6, TNF-α and clinical stages,ventilation function in elderly patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2013, (19): 4-6. DOI: 10.7619/jcmp.201319002
    [10]SUN Changjiang, FAN Hui, GE Jianbin. Effect of Xuebijing injection on serum concentrations of TNF-α, IL-1β and IL-6in patients with acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2013, (9): 83-85,90. DOI: 10.7619/jcmp.201309029
  • Cited by

    Periodical cited type(15)

    1. 马治娥,赵文娟,王沛. 不同质子泵抑制剂对胃溃疡患者胃肠激素及氧化应激的影响. 贵州医药. 2024(01): 55-56 .
    2. 孙敏. 四联疗法联合康复新液对消化性溃疡合并幽门螺杆菌感染患者的临床效果分析. 中国校医. 2024(01): 61-64 .
    3. 黄莉莉,黄晶晶. 奥美拉唑联合纤维蛋白粘合剂在消化性溃疡出血中的应用效果分析. 中国烧伤创疡杂志. 2024(03): 240-244 .
    4. 王燕,宋建国,李红,温爽,付琳璐. 雷尼替丁联合消化内镜对十二指肠溃疡的治疗效果. 中国医药指南. 2024(16): 86-89 .
    5. 刘雅红. 单用质子泵抑制剂治疗消化性溃疡对根除幽门螺杆菌的影响. 中国现代药物应用. 2024(14): 112-114 .
    6. 白玲,赵琴. 血清谷胱甘肽过氧化物酶、脂质过氧化物水平与妊娠期糖尿病及其糖脂代谢异常、胰岛素抵抗和母婴结局的关系. 安徽医药. 2024(11): 2226-2230 .
    7. 陈偲. 小组式知信行健康宣教在消化道溃疡患者中的应用. 江苏卫生事业管理. 2024(10): 1420-1422 .
    8. 王建东. 愈疡健脾方联合质子泵抑制剂治疗脾胃虚寒型消化性溃疡的临床观察. 基层医学论坛. 2024(36): 153-156 .
    9. 陈波,张庆团,黄克锋,杨燕芬,熊弋平. 瑞巴派特四联疗法对幽门螺杆菌阳性消化性溃疡患者血清氧化应激指标和胃蛋白酶原的影响. 现代生物医学进展. 2023(11): 2168-2172 .
    10. 黄小花. 健胃愈疡汤辅助四联疗法治疗十二指肠溃疡的效果及对溃疡面积、胃肠相关指标的影响. 临床合理用药. 2023(29): 81-84 .
    11. 俞洪韵,陈慧丽,朱锋,汪璇,陶治华. 健胃愈疡颗粒联合西咪替丁治疗重症患者应激性溃疡的临床研究. 现代药物与临床. 2023(10): 2506-2510 .
    12. 胡量. 康复新液治疗胃溃疡的临床疗效及对炎性因子、氧化应激和胃黏膜修复作用的影响分析. 现代诊断与治疗. 2023(17): 2543-2545+2556 .
    13. 陆文鹏,陈民,陈洁,郑新梅,董小耘. 基于生物信息学探讨败酱散调控氧化应激缓解克罗恩病的机制. 实用临床医药杂志. 2022(16): 11-17 . 本站查看
    14. 黄以治. 胃黏膜保护剂联合质子泵抑制剂治疗消化性溃疡伴出血的临床效果. 中国医药指南. 2022(35): 29-32 .
    15. 张珊珊,刘畅,阴雨龙. 奥美拉唑与雷尼替丁治疗十二指肠溃疡的疗效对比分析. 中外医疗. 2022(31): 136-139 .

    Other cited types(3)

Catalog

    Article views PDF downloads Cited by(18)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return